Bank of America’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,500
Closed -$991K 8289
2021
Q4
$991K Buy
+1,500
New +$1.15M ﹤0.01% 5267

Other funds holding CDLX

Bank of America's CDLX Position: Q1 2026 in Review

Bank of America reduced its Cardlytics (CDLX) stake by 98% in Q1 2026, selling an estimated $1.39M and leaving 3,546 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5626.

Bank of America first reported a position in CDLX in Q1 2018 and has held it in 33 quarters since. The position peaked at $24.2M in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Bank of America held 3,546 shares of Cardlytics worth $37.2K as of Q1 2026.
  • Bank of America sold 142,458 Cardlytics shares in Q1 2026, an estimated $1.39M.
  • Cardlytics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5626 holding.
  • Bank of America first reported a position in Cardlytics in Q1 2018 and has held it in 33 quarters since.
  • Bank of America's Cardlytics position peaked at $24.2M in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.